Efficacy and Safety of Spironolactone Versus Bicalutamide in Female Pattern Hair Loss: A Retrospective Comparative Study
May 2024
in “
Australasian journal of dermatology
”
Studysummary In this study, researchers found that bicalutamide was more effective and had a better safety profile than spironolactone for treating female-pattern hair loss in women aged 18 to 50, based on the Sinclair scale and photographic assessments after 24 weeks of treatment.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →